Non-invasive cancer diagnostics Market Trends, Size, Forecast - 2017-2022

The global Non-invasive cancer diagnostics market is expected to grow at the CAGR of 7.2% during 2017-2022. Rising chronic cancers with a growing demand of minimally invasive Diagnostics are driving the non-invasive cancer Diagnostics market across the globe. Non-invasive cancer diagnostic market is an approach used for detection of the cancer conditions with minimal incision in body during diagnosis. According to WHO, 14 million cases of cancer were reported and 8.2 million died in 2012. The numbers of fatalities have been increased to 8.8 million during 2015-16. This significant number of cancer cases has shifted the global attention towards the adoption of early detection and diagnosis techniques for cancer.

Request a free sample of our report on Non-invasive cancer diagnostics Market : https://www.omrglobal.com/request-sample/non-invasive-cancer-diagnostics-market

Additionally, the growing awareness programs and initiatives by government and healthcare organizations are boosting the market growth across the globe. Cancer Research UK, the Department of Health, NHS England and Public Health England in collaboration has launched National Awareness and Early Diagnosis Initiative (NAEDI). The initiative aims to increase awareness of the signs and symptoms of cancer amongst the general public and medical professionals, and to promote early diagnosis. Many more number of such initiatives are creating awareness among global patients for diagnosis and treatment of cancer.

A full report of Non-invasive cancer diagnostics Market is available at : https://www.omrglobal.com/industry-reports/non-invasive-cancer-diagnostics-market

Non-invasive cancer diagnosis market

By type
• Blood cancer
• Solid tumors
• Breast cancer
• Lung cancer
• Others

By techniques
• Clinical chemistry
• Immunochemistry/immunoassay
• Molecular diagnostics
• Other clinical instruments

Competitive landscape
• Key strategies
• Key company analysis

Regional analysis

• North america
o United states
o Canada
o Rest of north america

• Europe
o United kingdom
o France
o Germany
o Italy
o Spain
o Rest of europe

• Asia pacific
o India
o China
o Japan

• Rest of the world

Company profiles

• A&g pharmaceutical, inc.
o Introduction
o A7g pharmaceutical product portfolio
o A&g pharmaceutical recent activities

• Accelerate brain cancer cure
o Introduction
o Accelerate brain cancer cure product portfolio
o Accelerate brain cancer cure recent activities

• Admera health innovations
o Introduction
o Admera health innovations product portfolio
o Admera health innovations recent activities

• Affymetrix inc.
o Introduction
o Affymetrix inc. Product portfolio
o Affymetrix inc. Recent activities

• Aviva biosciences corporation
o Introduction
o Aviva biosciences corporation product portfolio
o Aviva biosciences corporation recent activities

• Bioview inc.
o Introduction
o Bioview inc. Product portfolio
o Bioview inc. Recent activities

• Cynvenio biosystems
o Introduction
o Cynvenio biosystems product portfolio
o Cynvenio biosystems recent activities

• Digene corporation
o Introduction
o Digene corporation product portfolio
o Digene corporation recent activities

• Exosomics siena
o Introduction
o Exosomics siena product portfolio
o Exosomics siena recent activities

• Flariton health
o Introduction
o Flariton health product portfolio
o Flariton health recent activities

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/non-invasive-cancer-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.